Rethinking Mental Health with Precision.
The future of mental health treatments with targeted noninvasive ultrasound therapy.
Our Mission
We envision a world where anyone with mental health issues has access to precision neurotherapeutics that provide targeted, safe treatments and that enable their path to comprehensive well-being while respecting their autonomy.
Our team of world-leading experts is building that world with low-intensity transcranial ultrasound neuromodulation.
Available Soon
Sanmai's first clinical device called Lotus will be available at the end of 2024. Clinics interested in our medical device can contact us for more information.
Safe. Effective. Accessible.
Sanmai was created as a public benefit corporation by world-leading experts in neuromodulation and ultrasound, clinical science and engineering.
FEATURED NEWS
Keep up to date with Sanmai's progress and field-leading research.
Clinical Study • Posted 2023-12-13
The Effects of Noninvasive Neuromodulation on Mental Wellness, Behavior, and Electrophysiology
The purpose of the study is to test the effects of brief, low-intensity transcranial focused ultrasound (TUS) on electrophysiological, behavioral, and cognitive markers related to anxiety disorders.
